Results 121 to 130 of about 2,872,365 (306)

Mechanisms of an Inhibitory Control Training to Reduce Binge Eating—The Randomized Controlled MIND BINGES Trial

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Psychotherapy is the first‐line treatment for eating disorders (EDs), yet only about half of patients benefit long‐term. Bulimia nervosa (BN), Binge‐Eating‐Disorder (BED), and non‐underweight EDs with regular binge eating (> 2 binge‐eating episodes per month within the last 3 months) (OSFED/UFED) form a transdiagnostic group ...
Sebastian M. Max, Katrin E. Giel, Christian Plewnia, Simone Weller, Andreas J. Fallgatter, Veronika Lossa, Stephan Zipfel, Kathrin Schag   +7 more
wiley   +1 more source

Low Hepatitis C Reinfection Following Direct-Acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Clinical Infectious Diseases, 2019
BACKGROUND Direct acting antiviral (DAA) therapy is highly effective in PWID; however, rates, specific injection behaviors, and social determinants of drug use associated with HCV reinfection following DAA therapy among PWID on opioid agonist therapy ...
M. Akiyama, Daniel Lipsey, M. Heo, L. Agyemang, B. Norton, Jennifer Hidalgo, Kiara Lora, A. Litwin   +7 more
semanticscholar   +1 more source

Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.

Pain Physician, 2020
BACKGROUND Acute pain management in patients on buprenorphine opioid agonist therapy (BOAT) can be challenging. It is unclear whether BOAT should be continued or interrupted for optimization of postoperative pain control.
D. Mehta, V. Thomas, J. Johnson, B. Scott, Sandra C. Cortina, Landon Berger   +5 more
semanticscholar   +1 more source

Opium continuum of care cascade for people experiencing probation in Ukraine.

, 2023
OAT = Opioid Agonist Therapy, BI = Brief Intervention.
Faye Taxman (8488884), Daniel J. Bromberg (14008932), Lyu Azbel (14008941), Nataliia Saichuk (17319343), Frederick L. Altice (7537310), Samy J. Galvez de Leon (14046367), Amanda R. Liberman (5064113), Maxim Polonsky (14046364), Sergii Dvoriak (14046370), Taylor Litz (14008935)   +9 more
core   +1 more source

Fatalities within seven days after equine standing sedation: A prospective, multicentre study

Equine Veterinary Journal, EarlyView.
Abstract Background Information regarding mortality associated with standing procedures in horses is sparse. Objectives To report data from >12,000 standing sedations. Study Design Confidential, observational, prospective, multicentre, cohort study.
Miguel Gozalo‐Marcilla, José I. Redondo, Polly M. Taylor, Luis Domenech, Javier Doménech, Gordon Mark Johnston, Regula Bettschart‐Wolfensberger   +6 more
wiley   +1 more source

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis

Addiction, 2020
Background and aim Globally, nearly one in five people who inject drugs (PWID) are living with HIV, and the rate of new HIV infections in PWID is increasing in some settings. Early diagnosis is crucial for effective HIV control.
Claire F. Ferraro, D. Stewart, J. Grebely, L. Tran, Shally Zhou, C. Puca, B. Hajarizadeh, S. Larney, Thomas Santo, J. Higgins, P. Vickerman, L. Degenhardt, M. Hickman, C. French   +13 more
semanticscholar   +1 more source

A Novel Application of the Volumetric Absorptive Micro Sampling Strategy to Quantify Dexmedetomidine in Capillary Blood Using an LC–MS/MS Method

Journal of Clinical Laboratory Analysis, EarlyView.
This study introduces a novel application of MITRA devices for collecting capillary blood to quantify dexmedetomidine using a newly developed and validated LC–MS/MS method. The highly sensitive developed method was successfully applied to analyze patient whole blood samples.
Lorena Lucatello, Martina Franzin, Gabriele Stocco, Jenny Bua, Francesca Cossovel, Riccardo Addobbati, Francesca Capolongo   +6 more
wiley   +1 more source

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study

Journal of Viral Hepatitis, 2019
The aim of this analysis was to evaluate perceived barriers related to HCV testing, management and treatment among physicians practicing in clinics offering opioid agonist treatment (OAT).
A. Litwin, M. Drolet, Chizoba U. Nwankwo, M. Torrens, A. Kastelic, S. Walcher, L. Somaini, Emily Mulvihill, J. Ertl, J. Grebely   +9 more
semanticscholar   +1 more source

Addressing in‐hospital substance use: A bioethical evaluation of two possible approaches

Journal of Hospital Medicine, EarlyView.
Abstract Up to 40% of patients with substance use disorder report using non‐prescribed drugs when hospitalized. In‐hospital substance (IHSU) use is associated with poor outcomes and raises safety concerns for healthcare providers. Despite its prevalence, little guidance exists regarding best practices in responding to IHSU.
John C. Messinger, Taylor Baisey, Johanna Sluser, Benjamin A. Barsky, Marlene Martin, Leslie W. Suen   +5 more
wiley   +1 more source

Maintenance pharmacologic therapies for opioid use disorders: beyond opioid agonists

Romanian Journal of Military Medicine, 2019
Opioid use disorder is a worldwide challenge for an increasing number of patients, and still the therapeutic options presented in clinical guidelines for this condition are very few. The first line pharmacological therapies for opioid use disorder continue to be opioid agonists as substitution treatment, but the need to find new treatments without ...
openaire   +1 more source